Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.38 USD | -0.68% | +1.86% | +143.33% |
03-22 | H.C. Wainwright Adjusts Price Target on Pyxis Oncology to $7 From $4, Maintains Buy Rating | MT |
03-21 | Health Care Up on Drug Sales Optimism -- Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+143.33% | 258M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- PYXS Stock
- News Pyxis Oncology, Inc.
- BofA Securities Starts Pyxis Oncology at Neutral With $16 Price Target